Lipoprotein lipase gene variants and risk of coronary disease: A quantitative analysis of population-based studies

International Journal of Clinical and Laboratory Research

Volumn 27, Issue 1, 1997, Pages 24-34

  Hokanson, J E ^a,b  

^a Division of Metabolism   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Coronary disease; High density lipoprotein; Linkage disequilibrium; Lipoprotein lipase gene; Triglyceride

Indexed keywords

EID: 0030745465     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02827239     Document Type: Article

References (105)

1. Havel RJ, Gordon RS Jr. Idiopathic hyperlipidemia: metabolic studies in an affected family. J Clin Invest 1960; 39: 1777.
2. Magill P, Rao SN, Miller NE, Nicoll A, Brunzell J, St Hilaire J, Lewis B. Relationships between the metabolism of high-density and very-low-density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity. Eur J Clin Invest 1982; 12: 113.
3. Brunzell JD, Hazzard WR, Porte D Jr, Bierman EL. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest 1973; 52: 1578.
4. Havel RJ, Kane JP. Structure and metabolism of plasma lipoproteins. In: Scriver CR et al., eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 1995: 1841.
5. Goldberg IJ, Le NA, Paterniti JR Jr, Ginsberg HN, Lindgren FT, Brown WV. Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. J Clin Invest 1982; 70: 1184.
6. Demant T, Carlson LA, Holmquist L, Karpe F, Nilsson Ehle P, Packard CJ, Shepherd J. Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. J Lipid Res 1988; 29: 1603.
7. Nikkila EA, Taskinen MR, Kekki M. Relation of plasma high-density lipoprotein cholesterol to lipoprotein-lipase activity in adipose tissue and skeletal muscle of man. Atherosclerosis 1978, 29: 497.
8. Patsch JR, Gotto AM Jr, Olivercrona T, Eisenberg S. Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci USA 1978; 75: 4519.
9. Brinton EA, Eisenberg S, Breslow JL. Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women. J Clin Invest 1989; 84: 262.
10. Goldberg IJ, Blaner WS, Vanni TM, Moukides M, Ramakrishnan R. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys. J Clin Invest 1990; 86: 463.
11. Beisiegel U, Weber W, Bengtsson Olivecrona G. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc Natl Acad Sci USA 1991; 88: 8342.
12. Mulder M, Lombardi P, Jansen H, Berkel TJ van, Frants RR, Havekes LM. Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase. J Biol Chem 1993; 268: 9369.
13. Argraves KM, Battey FD, MacCalman CD, McCrae KR, Gafvels M, Kozarsky KF, Chappell DA, Strauss J Fr, Strickland DK. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes. J Biol Chem 1995; 270: 26550.
14. Salinelli S, Lo J-Y, Mims MP, Zsigmond E, Smith LC, Chan L. Structure-function relationship of lipoprotein lipase-mediated enhancement of very low density lipoprotein binding and catabolism by the low density lipoprotein receptor. J Biol Chem 1996; 271: 21906.
15. Brunzell JD. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: Scriver CR et al., eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 1995: 1913-1932.
16. Krauss RM, Levy RI, Fredrickson DS. Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia. J Clin Invest 1974; 54: 1107.
17. Cantin B, Brun LD, Gagné C, Murthy MR, Lupien PJ, Julien P. Alterations in erythrocyte membrane lipid composition and fluidity in primary lipoprotein lipase deficiency. Biochim Biophyh Acta 1992; 1139: 25.
18. Zambon A, Torres A, Bijvoet S, Gagné C, Moorjani S, Lupien PJ, Hayden MR, Brunzell JD. Prevention of raised low-density lipoprotein cholesterol in a patient with familial hypercholesterolaemia and lipoprotein lipase deficiency. Lancet 1993; 341: 1119.
19. Gagné C, Brun LD, Julien P, Moorjani S, Lupien PJ. Primary lipoprotein-lipase-activity deficiency: clinical investigation of a French Canadian population Can Med Assoc J 1989; 140: 405
20. Benlian P, DeGennes JL, Foubert L, Zhang H, Gagné SE, Hayden M. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med 1996; 335: 848.
21. Langlois S, Deeb S, Brunzell JD, Kastelein JJ, Hayden MR. A major insertion accounts for a significant proportion of mutations underlying human lipoprotein lipase deficiency. Proc Natl Acad Sci USA 1989; 86: 948
22. Murthy V, Julien P, Gagne C. Molecular pathobiology of the human lipoprotein lipase gene. Pharmacol Ther 1996; 70: 101.
23. Evans D, Besch T, Brummer D, Altenburg C, Beisiegel U. The lipoprotein lipase (LpL) gene in patients with hyperlipoproteinemia (HLP). Proceedings of the 66th Congress of the European Atherosclerosis Society; 1996, July 13-17; Florence. Florence: Foundazione Giovanni Lorenzini, 1996.
24. Zhang Q, Cavallero E, Cavanna J, Kay A, Charles A, Braschi S, Perlemutter L, Jacotot B, Galton DJ, Lipemia, diabetes m. and obesity: mutations at the lipoprotein lipase (LPL) gene locus Proceedings of the 66th Congress of the European Atherosclerosis Society; 1996, July 13-17; Florence. Florence: Foundazione Giovanni Lorenzini, 1996.
25. Calandra S, Simone ML, Bertolini S. New mutations of lipoprotein lipase gene in Italian patients with hyperchylomicronemia. Proceedings of the 66th Congress of the European Atherosclerosis Society: 1996, July 13-17; Florence. Florence: Fondazione Giovanni Lorenzini, 1996.
26. Julien P. High frequency of lipoprotein liase deficiency in the Quebec population. Can J Cardiol 1992; 8: 675.
27. Lohse P, Beg O, Brunzell JD, Santamarina-Fojo S, Brewer HB Jr. Familial chylomicronemia: identification of a unique patient homozygote for two separate mutations m the LPL gene. Arterioscler Thromb 1991; 11: 1415.
28. Rouis M, Lohse P, Dugi KA, Lohse P, Beg OU, Ronan R, Talley GD, Brunzell JD, Santamarina-Fojo S. Homozygosity for two point mutations in the lipoprotein lipase (LPL) gene in a patient with familial LPL deficiency: LPL(Asp9->Asn. Tyr262->His). J Lipid Res 1996; 37: 651.
29. Ma Y, Zhang H, Liu M-S, Frohlich J, Brunzell JD, Hayden MR. Type III hyperlipoproteinemia in apoE2/2 homozygotes: possible role of mutations in the lipoprotein lipase gene. Circulation 1993; 88: I.
30. Zhang H, Reymer PW, Liu MS, Forsythe IJ, Groenemeyer BE, Frohlich J, Brunzell JD, Kastelein JJ, Hayden MR, Ma Y. Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291->Ser mutation in the human LPL gene. Arterioscler Thromb Vasc Biol 1995; 15: 1695.
31. Busca R, Peinado J, Vilella E, Auwerx J, Deeb SS, Vilaró S, Reina M. The mutant Asn291->Ser human lipoprotein lipase is associated with reduced catalytic activity and does not influence binding to heparin. FEBS Lett 1995; 367: 257.
32. Reymer PW, Gagn'e E, Groenemeyer BE, Zhang H, Forsyth I, Jansen H, Seidell JC, Kromhout D, Lie KE, Kastelein J, et al. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis Nat Genet 1995; 10: 28.
33. Zhang H, Henderson H, Gagne SE, Clee SM, Miao L, Liu G, Hayden MR. Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochim Biophys Acta 1996; 1302: 159.
34. Assmann G, Cullen P, Schulte H. Risk factors - from epidemiology to genetics in the Munster Heart Study (PROCAM). Proceedings of the 66th Congress of the European Atherosclerosis Society; 1996. July 13-17; Florence. Florence: Foundazione Giovanni Lorenzini, 1996
35. Mailly F, Tugrul Y, Reymer PW, Bruin T, Seed M, Groenemeyer BF, Asplund Carlson A, Vallance D, Winder AF, Miller GJ, et al. A common variant in the; gene for lipoprotein lipase (Asp9->Asn). Functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler Thromb Vasc Biol 1995; 15: 468.
36. Mailly F, Fisher RM, Nicaud V, Luong L-A, Evans AE, Marques-Vidal P, Luc G, Arveiler D, Bard JM, Poirier O, Talmud PJ, Humphries SE. Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors form the ECTIM study. Atherosclerosis 1996; 122: 21.
37. Elbein SC, Yeager C, Kwong LK, Lingam A, Inoue I, Lalouel JM, Wilson DE. Molecular screening of the lipoprotein lipase gene in hypertriglyceridemic members of familial noninsulin-dependent diabetes mellitus families. J Clin Endocrinol Metab 1994; 79: 1450.
38. Hata A, Robertson M, Emi M, Lalouel JM. Direct detection and automated sequencing of individual alleles after electrophoretic strand separation: identification of a common non-sense mutation in exon 9 of the human lipoprotein lipase gene. Nucleic Acids Res 1990; 18: 5407.
39. Peacock RE, Hamsten A, Nilsson Ehle P, Humphries SE. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis 1992; 97: 171.
40. Mattu RK, Needham EW, Morgan R, Rees A, Hackshaw AK, Stocks J, Elwood PC, Galton DJ. DNA variants at the LPL gene locus associate with angiographically defined seventy of atherosclerosis and serum lipoprotein levels in a Welsh population. Arterioscler Thromb 1994; 14: 1090.
41. Kobayashi J, Nishida T, Ameis D, Stahnke G, Schotz MC, Hashimoto H, Fukamachi I, Shirai K, Saito Y, Yoshida S. A heterozygous mutation (the codon for Ser447 - a stop codon) in lipoprotein lipase contributes to a defect in lipid interface recognition in a case with type I hyperlipidemia. Biochem Biophys Res Commun 1992; 182: 70.
42. Jukema JW, Boven AJ van, Groenemeijer B, Zwinderman AH, Reiber JHC, Bruschke AVG, Bruin T, Hayden MR, Gagné E, Kastelein JJP. The asp9asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. Circulation 1996; 94: 1913.
43. Chamberlain JC, Thorn JA, Morgan R, Bishop A, Stocks J, Rees A, Oka K, Galton DJ. Genetic variation at the lipoprotein lipase gene associates with coronary atherosclerosis. In: Malmendier CL, ed. Hypercholesterolemia, hypocholesterolemia, hypertrielyceridemia. New York: Plenum Press; 1990: 275-279.
44. Thorn JA, Chamberlain JC, Alcolado JC, Oka K, Chan L, Stocks J, Galton DJ. Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis. Atherosclerosis 1990; 85: 55.
45. Fisher RM, Mailly F, Peacock RE, Hamsten A, Seed M, Yudkin JS, Beisiegel U, Feussner G, Miller G, Humphries SE, et al. Interaction of the lipoprotein lipase asparagine 291->serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. J Lipid Res 1995; 36: 2104.
46. Ukkola O, Savolainen MJ, Salmela PI, Dickhoff K von, Kesaniemi YA. DNA polymorphisms at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non-insulin-dependent) diabetes mellitus. Atherosclerosis 1995, 115: 99.
47. Jemaa R, Fumeron F, Poirier O, Lecerf L, Evans A, Arveiler D, Luc G, Cambou JP, Bard JM, Fruchart JC, et al. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas T'emoin sur l'Infarctus du Myocarde. J Lipid Res 1995; 36: 2141.
48. Zhang Q, Cavanna J, Winkelman BR, Shine B, Gross W, Marz W, Galton DJ Common genetic variants of lipoprotein lipase that relate to lipid transport in patients with premature coronary artery disease. Clin Genet 1995, 48: 293-298.
49. Wang XL, McCredie RM, Wilcken DE. Common DNA polymorphisms at the lipoprotein lipase gene. Association with severity of coronary artery disease and diabetes. Circulation 1996; 93: 1339.
50. Wittrup HH, Tybjaerg-Hansen A, Steffensen R, Reeler S, Schnohr P, Nordestgaard BG. Mutation in lipoprotein lipase associated with increased risk of ischemic heart disease in women, but not in men Circulation 1996; 94: 92
51. Heizmann C, Kirchgessner T, Kwiterovich PO, Ladias JA, Derby C, Antonarakis SE, Lusis AJ. DNA polymorphism haplotypes of the human lipoprotein lipase gene: possible association with high density lipoprotein levels. Hum Genet 1991; 86: 578.
52. Chen L, Patsch W, Boerwinkle E. HindIII DNA polymorphism in the lipoprotein lipase gene and plasma lipid phenotypes and carotid artery atherosclerosis. Hum Genet 1996; 98: 551.
53. Mattu RK, Needham EWW, Laban C, Haldo O, Yarnell J, Sweetnam P, Galton DJ. A common mutation of the lipoprotein lipase gene protects against coronary artery disease in the Caerphilly study. Abstracts of the 69th Scientific Session of the American Heart Association; 1996, November 10-13; New Orleans. Dallas: American Heart Association, 1996: 126.
54. Mantel N, Haenszel W. Statistical aspects of the analysis of data from reterospective studies of disease. J Natl Cancer Inst 1959; 22: 719.
55. Khoury MJ, Beaty TH, Cohen BH. Fundamentals of genetic epidemiology. Monogr Epidemiol Biostatistics 1993; 19: 118.
56. Greenland S. A meta-analysis of coffee, myocardial infarction, and coronary death. Epidemiology 1993; 4: 366.
57. Oka K, Tkalcevic GT, Nakano T, Tucker H, Ishimura Oka K, Brown WV. Structure and polymorphic map of human lipoprotein lipase gene [published erratum appears m Biochim Biophys Acta 1991; 1090: 357]. Biochim Biophys Acta 1990; 1049: 21.
58. De Bruin TWA, Mailly F, Van Barlingen HHJJ, Fisher R, Castro Cabezas M, Talmud P, Dallinga-Thie GM, Humphries SE. Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidemia. J Clin Invest 1996; 26: 631.
59. Reymer PW, Groenemeyer BE, Gagn'e E, Miao L, Appelman EE, Seidel JC, Kromhout D, Bijvoet SM, Oever K van de, Bruin T, et al. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Hum Mol Genet 1995; 4: 1543.
60. Pimstone SN, Clee SM, Gagne SE, Miao L, Zhang H, Stein EA, Hayden MR. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicrion triglyceride and retinyl palmitate response in normotipidemic carriers. J Lipid Res 1996; 37: 1675.
61. Hoffer MJV, Bredie SJH, Boomsma DI, Reymer PWA, Kastelein JJP, Knijff P de, Demacker PNM, Stalenhoef AFH, Havekes LM, Frants RR. The lipoprotein lipase (Asn291-> Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidemia. Atherosclerosis 1996; 119: 159.
62. Ahn YI, Kamboh MI, Hamman RF, Cole SA, Ferrell RE. Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J Lipid Res 1993; 34: 421.
63. Cole SA, Aston CE, Hamman RF, Ferrell RE. Association of a Pvu II RFLP at the lipoprotein lipase locus with fasting insulin levels in Hispanic men. Genet Epidemiol 1993; 10: 177.
64. Mitchell RJ, Earl L, Bray P, Fripp YJ, Williams J. DNA polymorphisms at the lipoprotein lipase gene and their association with quantitative variation in plasma high-density lipoproteins and triacylglycerides Hum Biol 1994; 66: 383.
65. Gerdes C, Gerdes LU, Hansen PS, Faergeman O. Polymorphisms in the lipoprotein lipase gene and their associations with plasma lipid concentrations in 40-year-old Danish men. Circulation 1995; 92: 1765.
66. Munroe PB, Johnston A, Duke VM, Daniel HI, Bouloux PM, Lawson M, Caulfield MJ. Investigation of lipoprotein lipase (LPL) as a candidate gene for dyslipidaemic hypertension. J Hum Hypertens 1994, 8: 613.
67. Jemaa R, Tuzet S, Portos C, Betoulle D, Apfelbaum M, Fumeron F. Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people. Int J Obes Relat Metab Disord 1995; 19: 270.
68. Chamberlain JC, Thorn JA, Oka K, Galton DJ, Stocks J. DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects. Atherosclerosis 1989; 79. 85.
69. Hegele RA, Evans AJ, Tu L, Ip G, Brunt H, Connelly PW. A gene-gender interaction affecting plasma Hpoproteins in a genetic isolate. Arterioscler Thromb 1994; 14: 671.
70. Hokanson JE, Austin MA. Plasma triglyceride is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3: 213
71. Gerdes C, Fisher RM, Nicaud V, Boer J, Humphries SE, Talmud PJ, Faergeman O. Lipoprotein lipase variants D9N and N291S - studies in the fasting and postprandial states. Proceedings of the 66th Congress of the European Atherosclerosis Society; 1996. July 13-17, Florence. Florence: Foundazione Giovanni Lorenzini, 1996.
72. Ma Y, Liu MS, Ginzinger D, Frohlich J, Brunzell JD, Hayden MR. Gene-environment interaction in the conversion of a mild-to-severe phenotype in a patient homozygous for a Ser172->Cys mutation in the lipoprotein lipase gene. J Clin Invest 1993; 91: 1953.
73. Brunzell JB, Austin MA, Deeb SS, Hokanson JE, Jarvik GR Nevin DN, Wijsman E, Zambon A, Motulsky AG. Familial combined hyperlipidemia and genetic risk for atherosclerosis. In: Woodford FP, Davignon J, Sniderman A, eds Atherosclerosis X. Amsterdam: Elsevier: 1995: 624-627.
74. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973; 52: 1544.
75. Hazzard WR, Goldstein JL, Schrott MG, Motulsky AG, Bierman EL. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction. J Clin Invest 1973; 52: 1569.
76. Brunzell JD, Albers JJ, Chait A, Grundy SM, Groszek E, McDonald GB. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res 1983; 24: 147.
77. Krauss RM, Albers JJ, Brunzell RM. An apolipoprotein B-enriched low density lipoprotein subspecies in familial combined hyperlipidemia. Clin Res 1983; 31: 503.
78. Hokanson JE, Krauss RM, Albers JJ, Austin MA, Brunzell JD. LDL physical and chemical properties m familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 1995; 15: 452.
79. Austin MA, Brunzell JD, Fitch WL, Krauss RM. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis 1990; 10: 520.
80. Kwiterovich POJ. Genetics and molecular biology of familial combined hyperlipidemia. Curr Opin Lipidol 1993; 4: 133.
81. Jarvik GP, Brunzell JD, Austin MA, Krauss RM, Motulsky AG, Wijsman R. Genetic predictors of FCHL in four large pedigrees. Influence of ApoB ievel major locus predicted genotype and LDL subclass phenotype. Arterioscler Thromb 1994; 14: 1687.
82. Cullen P, Farren B, Scott J, Farrall M. Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia. Arterioscler Thromb 1994, 14: 1233.
83. Jarvik GP, Beaty TH, Gallagher PR, Coates PM, Cortner JA. Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia Genet Epidemiol 1993; 10: 257.
84. Babirak SP, Iverius PH, Fujimoto WY, Brunzell JD. Detection and characterization of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis 1989; 9: 326.
85. Emi M, Wilson DE, Tverius PH, Wu L, Hata A, Hegele R, Williams RR, Lalouel JM. Missense mutation (Gly - Glu188) of human lipoprotein lipase imparting functional deficiency. J Biol Chem 1990, 265: 5910.
86. Wilson DE, Emi M, Iverius PH, Hata A, Wu LL, Hillas E, Williams RR, Lalouel JM. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J Clin Invest 1990; 86: 735.
87. Wilson DE, Hata A, Kwong LK, Lingam A, Shuhua J, Ridinger DN, Yeager C, Kaltenborn KC, Iverius PH, Lalouel JM. Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatitis, and non-insulin-dependent diabetes. J Clin Invest 1993; 92: 203.
88. Bijvoet S, Gagne' SE, Moorjani S, Gagné C, Henderson HE, Fruchart J-C, Dallongeville J, Alaupovic P, Prins M, Kastelein JJP, Hayden MR. Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency. J Lipid Res 1996; 37: 640.
89. Miesenbock G, Holzl B, Foger B, Brandstatter E, Paulweber B, Sandhofer F, Patsch JR. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest 1993; 91: 448.
90. Zambon A, Hokanson JE, Gagne C, Lupien PJ, Moorjani S, Hayden MR, Brunzell JD. Combined effect of familial hypercholesterolemia and lipoprotein lipase deficiency in determining low-density-lipoprotein size buoyancy, and lipid composition. J. Invest Med 1996; 44: A91
91. Minnich A, Kessling A, Roy M, Giry C, DeLangavant G, Lavigne J, Lussier Cacan S, Davignon J. Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent. J Lipid Res 1995; 36: 117
92. Babirak SP, Brown BG, Brunzell JD. Familial combined hyperlipidemia and abnormal lipoprotein lipase. Arterioscler Thromb 1992; 12: 1176.
93. Nevin DN, Brunzell JD, Deeb SS. The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity. Arterioscler Thromb 1994, 14: 869.
94. Talmud PJ, Hall S, Chu G, Ginesberg HN, Ramaskishnan R, Miller G, Humphries SE. Lipoprotein lipase -93T/G transition is associated with lower triglyceride levels and increases promoter activity in vitro. Circulation 1996; 94: 1.
95. Yang W-S, Nevin DN, Iwasaki L, Peng R, Brown BG, Brunzell JD, Deeb SS. Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease. J Clin Invest. In press.
96. Jukema JW, Bruschke AV, Boven AJ van, Reiber JH, Bal ET, Zwinderman AH, Jansen H, Boerma GJ, Rappard FM van, Lie KL, et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 1995; 91: 2528.
97. Zambon A, Brown BG, Hokanson JE, Brunzell JB. Hepatic lipase changes predict coronary artery disease progression/regression in the familial athersoclerosis treatment study (FATS). Circulation 1996; 94: I.
98. Nykjaer A, Nielsen M, Lookene A, Meyer N, Roigaard H, Etzerodt M, Beisiegel U, Olivecrona G, Gliemann J. A carboxyl-terminal fragment of lipoprotein lipase binds to the low density lipoprotein receptor-related protein and inhibits lipase-mediated uptake of lipoprotein in cells. J Biol Chem 1994; 269: 31747.
99. Gofman JW, DeLalla O, Flazier F, Freeman NK, Lindgren FT, Nichols AV, Strisower B, Tamplin AR. The serum lipoprotein transport system in health, metabolic disorders, atherosclerosis, and coronary disease. Plasma 1954; 2: 413.
100. Ott J, Associations between phenotype and alleles. In: Ott J, ed. Analysis of human genetic linkage. Baltimore: The Johns Hopkins University Press; 1991: 240-246.
101. Elston RC, Stewart J. A general model for the genetic analysis of pedigree data. Hum Hered 1971; 21: 523.
102. Ott J. Estimation of the recombination fraction in human pedigrees: efficient computation of the likelihood for human linkage studies. Am J Hum Genet 1974; 26: 588.
103. Haseman JK, Elston RC. The investigation of linkage between a quantitative trait and a marker locus. Behav Genet 1972; 2: 3.
104. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506
105. Risch N, Merikangas K. The future of genetic studies of complex diseases. Science 1996; 273: 1516.